# KCND1

## Overview
KCND1 is a gene that encodes the protein potassium voltage-gated channel subfamily D member 1, also known as Kv4.1, which is a crucial component of the voltage-gated potassium channel family. This protein is characterized as a transmembrane channel, consisting of six membrane-spanning segments and a pore domain that facilitates the selective passage of potassium ions. Kv4.1 is integral to the generation of A-type potassium currents, which are essential for the rapid repolarization phase of the cardiac action potential and play a significant role in neuronal excitability and signal transduction. The KCND1 gene is located on the X chromosome and is expressed in various tissues, including the brain, heart, liver, and kidney, underscoring its importance in both cardiac and neuronal functions (Isbrandt2000Gene). The protein's interactions with potassium channel interacting proteins (KChIPs) and its involvement in preventing cardiac hypertrophy through interactions with long non-coding RNAs further highlight its physiological significance (Cercós2021Pharmacological; Hou2022Long).

## Structure
The KCND1 gene encodes the Kv4.1 protein, a member of the voltage-gated potassium channel family, specifically the Kv4 subfamily. The protein consists of 647 amino acids, with a structure that includes six membrane-spanning hydrophobic segments (S1 to S6) and a pore domain between S5 and S6, which contains the potassium channel signature motif 'GYGD' (Isbrandt2000Gene). The Kv4.1 protein has intracellular N- and C-termini and shows a high degree of conservation in its core region, with 94% identity to the mouse orthologue mShal and 60% identity to other human Kv4 proteins, such as Kv4.2 and Kv4.3 (Isbrandt2000Gene).

Unlike most other Kvα subunits, Kv4.1 lacks the consensus site for N-glycosylation in the S1-S2 linker or at other sites (Isbrandt2000Gene). The protein is predicted to undergo post-translational modifications, including phosphorylation by protein kinases A and C, Ca2+/calmodulin-dependent protein kinase II, and MAP kinase, which may be important for its channel activity (Isbrandt2000Gene). The KCND1 gene is located on chromosome Xp11.23-p11.3 and is expressed in various human tissues, including the brain, heart, liver, and kidney (Isbrandt2000Gene).

## Function
The KCND1 gene encodes a protein that is part of the voltage-gated potassium channel family, specifically the Kv4.1 subunit, which plays a crucial role in mediating A-type potassium currents (I_TO and I_SA) in human cells. These channels are involved in the rapid repolarization phase of the cardiac action potential, contributing to the regulation of cardiac excitability and rhythm (Isbrandt2000Gene). In neurons, KCND1 is implicated in postsynaptic signal transduction and dendritic action potential propagation, influencing neuronal excitability and processes such as learning and memory (Isbrandt2000Gene).

The Kv4.1 protein, encoded by KCND1, is characterized by six membrane-spanning segments and a pore domain that is essential for potassium ion selectivity. This structure allows the channel to mediate fast-inactivating, transient outward potassium currents, which are important for maintaining the electrical excitability of cells (Isbrandt2000Gene). The expression of KCND1 is widespread across various tissues, including the brain, heart, liver, and kidney, indicating its significant role in both cardiac and neuronal functions (Isbrandt2000Gene). The protein's activity in the cell membrane is vital for processes like neurotransmission and muscle contraction, highlighting its importance in overall cellular and organismal physiology (Nerbonne2001Genetic).

## Clinical Significance
Mutations or altered expression of the KCND1 gene can significantly impact cardiac and neurological health. KCND1 encodes a protein that is part of the voltage-gated potassium channel family, which plays a crucial role in regulating electrical signaling in neurons and cardiac cells. Disruptions in the normal function of these channels can lead to cardiac arrhythmias, as the precise timing of electrical signals is essential for maintaining a regular heartbeat. In the nervous system, altered KCND1 expression or mutations can affect neuronal excitability, potentially contributing to various neurological disorders. These disruptions can lead to abnormal electrical activity in the brain, which may manifest as seizures or other neurological symptoms. The clinical significance of KCND1 is underscored by its involvement in these critical physiological processes, highlighting the importance of maintaining its normal function for overall health.

## Interactions
KCND1, encoding the Kv4.1 protein, is part of the voltage-gated potassium channel family and is involved in forming A-type currents in cardiac and neuronal tissues. The Kv4.1 protein interacts with potassium channel interacting proteins (KChIPs), which are essential for the modulation of its channel activity. These interactions are crucial for the proper trafficking and function of the Kv4 channels. KChIPs, such as KChIP1, form complexes with Kv4 channels, enhancing their trafficking to the plasma membrane and modulating their gating properties (Cercós2021Pharmacological).

The interaction between Kv4 channels and KChIPs involves specific structural conformations, such as the hydrophobic segment on the N-terminal side of the Kv4 channel interacting with a hydrophobic pocket in KChIP1. This interaction is vital for the modulation of the channel's electrical properties and is influenced by various compounds that can bind to KChIP proteins, altering their interaction with Kv4 channels (Cercós2021Pharmacological).

Additionally, KCND1 is associated with the regulation of cardiac hypertrophy through its interaction with the long non-coding RNA KCND1, which targets the protein YBX1. This interaction is significant in preventing hypertrophic effects in cardiac cells (Hou2022Long).


## References


[1. (Nerbonne2001Genetic) Jeanne M. Nerbonne, Colin G. Nichols, Thomas L. Schwarz, and Denis Escande. Genetic manipulation of cardiac k + channel function in mice: what have we learned, and where do we go from here? Circulation Research, 89(11):944–956, November 2001. URL: http://dx.doi.org/10.1161/hh2301.100349, doi:10.1161/hh2301.100349. This article has 173 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/hh2301.100349)

[2. (Cercós2021Pharmacological) Pilar Cercós, Diego A. Peraza, Angela de Benito-Bueno, Paula G. Socuéllamos, Abdoul Aziz-Nignan, Dariel Arrechaga-Estévez, Escarle Beato, Emilio Peña-Acevedo, Armando Albert, Juan A. González-Vera, Yoel Rodríguez, Mercedes Martín-Martínez, Carmen Valenzuela, and Marta Gutiérrez-Rodríguez. Pharmacological approaches for the modulation of the potassium channel kv4.x and kchips. International Journal of Molecular Sciences, 22(3):1419, January 2021. URL: http://dx.doi.org/10.3390/ijms22031419, doi:10.3390/ijms22031419. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22031419)

3. (Hou2022Long) Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1. This article has 1 citations.

[4. (Isbrandt2000Gene) Dirk Isbrandt, Thorsten Leicher, Ralph Waldschütz, Xinran Zhu, Ulrich Luhmann, Uwe Michel, Kathrin Sauter, and Olaf Pongs. Gene structures and expression profiles of three human kcnd (kv4) potassium channels mediating a-type currents ito and isa. Genomics, 64(2):144–154, March 2000. URL: http://dx.doi.org/10.1006/GENO.2000.6117, doi:10.1006/geno.2000.6117. This article has 108 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/GENO.2000.6117)